[1] Dmochowski M, Hashimoto T, Bhogal B, et al. Immunoblotting studies of linear IgA diseases. J Dermatol Sci, 1993,6:194-200. [2] Wojnarowska F, Whitehead P, Leigh IM, et al. Identification of the target antigen in chronic bullous disease of childhood and linear IgA diseases of adults. Br J Dermatol, 1991,124:157-162. [3] Ghohestani R, Nicolas J, Kanitakis J, et al. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180-or 230-kDa epidermal antigens. J Invest Dermatol, 1997,108:854-858. [4] Allen J, Zhou S, Wakelin S, et al. Linear IgA diseases: a report of two dermal binding sera which recognize a pepsin-sensitive epitope of collagen type VII. Br J Dermatol, 1997,137:526-533. [5] 张学军,王培光,翁孟武,等.自身免疫性大疱病中IgA型基底膜带抗体分析.中华皮肤科杂志,1999,32:393. [6] 张学军,翁孟武,施守义.热分离真表皮快速制备表皮下大疱病抗原.中华微生物学与免疫学杂志,1994,14:329-331. [7] Arechalde A, Braun P, Calza A, et al. Children bullous pemphigoid associated with IgA antibodies against BP180 or BP230 antigens. Br J Dermatol, 1999,140:112-118. [8] Egan C, Taylor T, Meyer L, et al. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A Domain. J Invest Dermatol, 1999,112:148-152. [9] Ishiko A, Shimizu H, Masunaga T, et al. 97kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180000a bullous pemphigoid antigen. J Invest Dermatol, 1998,111:93-96. [10] Zone J, Taylor T, Meyer L, et al. The 97 kDa linear IgA bullous diseases antigen is identical to a portion of the extracellular domain of the 180kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol, 1998, 110:207-210. |